Priscilla Chan and Mark Zuckerberg are dedicating a further $3.4 billion to biomedical and human health research on top of $3 billion invested several years ago, the organization announced this week.
Gamze Gursoy and Mark Gerstein of Yale Medical School have developed a strategy for stripping identifying variants from functional genomic data, balancing privacy with utility.